epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Alavert
    loratadine
  • remove benazepril/ hydrochlorothiazide
    generic
  • remove Casgevy
    exagamglogene autotemcel
  • remove Gammaplex
    immune globulin (human)
  • remove Kadian
    morphine sulfate

multicheck MultiCheck Results - 4 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face benazepril/hydrochlorothiazide (generic) + Gammaplex (immune globulin (human))

Monitor/Modify Tx


benazepril + immune globulin

monitor renal fxn; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

hydrochlorothiazide + immune globulin

monitor renal fxn; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of nephrotoxicity (additive effects)

Smiley face Smiley face benazepril/hydrochlorothiazide (generic) + Kadian (morphine sulfate)

Monitor/Modify Tx


benazepril + morphine

monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

hydrochlorothiazide + morphine

monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope; may decr. hydrochlorothiazide efficacy (additive effects; antagonistic effects, opioids may induce antidiuretic hormone release)

Additional Considerations

Smiley face Smiley face immune globulin in Gammaplex

monitor renal function; nephrotoxicity risk may be higher with sucrose-containing immune globulins, may vary depending on route of administration

Smiley face Smiley face morphine in Kadian

consider prescribing an opioid overdose reversal agent, especially with concomitant CNS depressant use

add MAO inhibitor to Interaction Check if recent (14 days) use

avoid combo with beverages or products containing ethanol and some morphine extended-release (ER) capsules; combo may incr. morphine release rate, levels, risk of adverse effects, including life-threatening overdose, decr. duration of efficacy

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information